title: Oral vaccines: directed safe passage to the front line of defense.
abstract: Oral vaccines are safe and easy to administer and convenient for all ages. They have been successfully developed to protect from many infectious diseases acquired through oral transmission. We recently found in animal models that formulation of oral vaccines in a nanoparticle-releasing microparticle delivery system is a viable approach for selectively inducing large intestinal protective immunity against infections at rectal and genital mucosae. These large-intestine targeted oral vaccines are a potential substitute for the intracolorectal immunization, which has been found to be effective against rectogenital infections but is not feasible for mass vaccination. Moreover, the newly developed delivery system can be modified to selectively target either the small or large intestine for immunization and accordingly revealed a regionalized immune system in the gut. Future applications and research endeavors suggested by the findings are discussed.
authors.affiliation: State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. zhuq_cams@126.com
authors.forename: Qing
authors.initials: Q
authors.lastname: Zhu
authors.forename: Jay A
authors.initials: JA
authors.lastname: Berzofsky
mesh_terms: D000284:Administration, Oral; D000818:Animals; D004337:Drug Carriers / Q000008:administration & dosage; D006801:Humans; D018928:Immunity, Mucosal; D007413:Intestinal Mucosa / Q000276:immunology*; D053758:Nanoparticles / Q000008:administration & dosage; D022462:Vaccines, Edible / Q000008:administration & dosage* / Q000009:adverse effects / Q000276:immunology*
chemical_list: D004337:Drug Carriers; D022462:Vaccines, Edible
keywords: T cell; intestine; mucosa; nanoparticle; oral vaccine; rectogenital infection